Multidisciplinary approach to evaluating immunogenicity of biosimilars: lessons learnt and open questions based on 10 years' experience of the European Union regulatory pathway

Overview of attention for article published in Biosimilars, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Anti-EGFR antibody and uses of same

Grant US-10759860-B2

United States of America

Anti-EGFR monoclonal antibody, methods of making, and uses thereof in the treatment of…

Application US-10118966-B2

United States of America